REMICADE (R)(Infliximab) First Anti-TNF Agent to be Recommended For EU Approval for Treating Ankylosing Spondylitis (PR Newswire)

- YAHOO.COM

...REMICADE is a monoclonal antibody that specifically targets and irreversibly binds to TNF-alpha....

Read the Entire Article

REMICADE (R)(Infliximab) First Anti-TNF Agent to be Recommended For EU Approval for Treating Ankylosing Spondylitis (PR Newswire) News Articles

REMICADE(R) (infliximab) Is The First Biologic Therapy Approved By The FDA To Induce And Maintain Clinical Remission In Patients With Moderate- To- Severe Crohn’s Disease (InternetWire)
... heart failure should not take REMICADE; so, prior to treatment, patients should discuss any heart condition with the...

Centocor Presents Long-Term Data From Accent II Trial With Remicade(R) (infliximab) In Maintaining Fistula Closures In Crohn’s Patients (InternetWire)
... heart failure should not take REMICADE; so, prior to treatment, patients should discuss any heart condition with the...

Promising Results Reported For REMICADE(R) (Infliximab) In The Treatment Of Psoriatic Arthritis (InternetWire)
... swelling and tenderness of the joints and the soft tissue around them; reduced range of motion; morning stiffness an...

Remicade(R) (Infliximab) is The First Biologic Therapy Approved by the FDA to Induce and Maintain Clinical Remission in Patients With Moderate- to- Severe Crohn’s Disease (PR Newswire)
... heart failure should not take REMICADE; so, prior to treatment, patients should discuss any heart condition with the...

Study Evaluates Impact of Treatment With REMICADE(R) (Infliximab) Plus Methotrexate on Employability and Time Lost From Work (PR Newswire)
... heart failure should not take REMICADE; so, prior to treatment, patients should discuss any heart condition with the...